HIND Cổ tức: Vyome Holdings Inc Cảnh báo về tỷ suất sinh lời



Cổ tức

HIND Cổ tức

Vyome Holdings Inc

$2.1

-4.54%

$-0.1

Khi đóng cửa: May 07, 16:00:00 GMT-4

$2.08

-0.53%

$-0.01

Phiên sau giờ: May 07, 20:00:00 GMT-4

Tổng quan Dự báo Thu nhập Cổ tức Tài chính

Thống kê chính

Giá đóng cửa trước

$2.2

Giá mở cửa

$2.19

Phạm vi ngày

$2.08 - $2.21

Phạm vi 52 tuần

$1.75 - $46.6

Khối lượng

6.1K

Khối lượng trung bình

597.7K

Tỷ suất cổ tức

EPS (TTM)

63.63

Vốn hóa thị trường

$14.6M

HIND là gì?

Vyome Holdings, Inc. engages in the development of immuno-inflammatory assets. The company is headquartered in San Clemente, California and currently employs 9 full-time employees. The company went IPO on 2016-10-06. The firm is focused on leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. Its clinical program VT1953 Gel is focused on cancer patients who are suffering from malignant fungating wounds (MFW). Its preclinical development program, VT1908, is a non-steroidal eye drop, which is focused on Uveitis. Its other business unit is focused on offering artificial intelligence (AI)-driven healthcare solutions across mental health and inflammation care, digital therapeutics and psychoneuroimmunology.